Acetyl tetrapeptide-5
is used in cosmetic eye formulations to decrease puffiness, eye bags, and dark circles by reducing edema and protecting proteins such as SOD from glycation
Alanine
Ala / A · hydrophobic residue · neutral charge
AOD-9604
is studied as an anti-obesity peptide that can reduce weight gain and increase fat oxidation in obese animal models with generally neutral effects on IGF-1 and glucose metabolism in early human trials
Arginine
Arg / R · basic residue · positive charge
Argireline
is a topical cosmetic peptide reported to decrease dynamic wrinkles by partially mimicking the mechanism of botulinum toxin in a non-invasive manner
Asparagine
Asn / N · polar residue · neutral charge
Aspartic acid
Asp / D · acidic residue · negative charge
BPC-157
is investigated for accelerating healing of gastrointestinal mucosa, tendons, ligaments, bone, and nervous tissue in preclinical models, with anti-inflammatory and pro-angiogenic effects
Comparison
While PEG-MGF is used experimentally to enhance muscle repair and hypertrophy after mechanical overload or injury by stimulating satellite-cell activation and protein synthesis6373138, Thymosin Beta-4 promotes wound healing, angiogenesis, and tissue regeneration in preclinical models via effects on cytoskeleton dynamics, cell migration, and anti-apoptotic pathways25579.
While PEG-MGF works as a poly(ethylene glycol)-conjugated form of Mechano Growth Factor (IGF-1Ec splice variant) comprising the 24-aa C-terminal E-peptide of IGF-1, designed to extend half-life while activating IGF-1 receptor–mediated anabolic signaling in muscle satellite cells637322138, Thymosin Beta-4 is an endogenous 43-amino-acid actin-sequestering peptide that maintains a pool of G-actin monomers and regulates actin polymerization, thereby influencing cell migration, proliferation, and differentiation25579.
PEG-MGF
IGF1
Thymosin Beta-4
TMSB4X
Both peptides fall into a similar broad context as Signal peptides, although the details of how they are used and discussed still diverge. Both are often discussed in Musculoskeletal health and Cardiovascular health contexts, while PEG-MGF is more of a signal peptide and Thymosin Beta-4 is better described as a cytokine peptide. Both appear to work through Signaling modulator, but the functional emphasis still separates, with PEG-MGF leaning toward Anabolic growth and Thymosin Beta-4 leaning toward Angiogenesis modulation and Anti-inflammatory. PEG-MGF has a more synthetic analog origin, while Thymosin Beta-4 is closer to natural endogenous background with PEG-MGF in Preclinical development and Thymosin Beta-4 in Clinical phase 2. PEG-MGF takes the form of a peptide conjugate, whereas Thymosin Beta-4 is closer to a linear peptide, while PEG-MGF carries pegylation features, while Thymosin Beta-4 instead reflects acetylation changes.